Dr Thomas Elisha Strong Jr, MD | |
1455 Joco Ln, Moneta, VA 24121-5672 | |
(540) 297-1984 | |
Not Available |
Full Name | Dr Thomas Elisha Strong Jr |
---|---|
Gender | Male |
Speciality | Orthopaedic Surgery |
Location | 1455 Joco Ln, Moneta, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053452995 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 0101016629 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Thomas Elisha Strong Jr, MD 1455 Joco Ln, Moneta, VA 24121-5672 Ph: (540) 297-1984 | Dr Thomas Elisha Strong Jr, MD 1455 Joco Ln, Moneta, VA 24121-5672 Ph: (540) 297-1984 |
News Archive
As primary caregivers, parents are often believed to have a strong influence on children's eating behaviors. However, previous findings on parent-child resemblance in dietary intakes are mixed. Researchers from the Johns Hopkins Bloomberg School of Public Health reviewed and assessed the degree of association and similarity between children's and their parents' dietary intake based on worldwide studies published since 1980. The meta-analysis is featured in the December issue of the Journal of Epidemiology and Community Health.
An opioid use score based on state prescription databases does not predict complications or other adverse outcomes in patients undergoing spinal surgery, reports a study in the journal Spine.
DPI effectively switches off the cancer stem cells, preventing their proliferation. "It's extraordinary; the cells just sit there as if in a state of suspended animation" explains Professor Michael Lisanti, Chair of Translational Medicine and lead investigator.
There is new hope for the treatment of Alzheimer's and other neurological diseases following a ground-breaking discovery made by an Australian-Chinese research collaboration.
For children receiving kidney transplants, a potentially correctable blood condition present in about one in four recipients is associated with a moderately increased risk of the graft's later failure, suggesting that clinicians should weigh whether transplant is advisable when the condition is present, according to UC Davis research presented today at the 24th International Congress of the Transplantation Society in Berlin.
› Verified 2 days ago